Emmerich Ilka Ute
Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät der Universität Leipzig.
Tierarztl Prax Ausg G Grosstiere Nutztiere. 2021 Apr;49(2):133-138. doi: 10.1055/a-1428-8570. Epub 2021 Apr 26.
In 2020, one novel pharmaceutical agent for horses or food-producing animals was released on the German market, rendering the inhaled glucocorticoid ciclesonide (Aservo EquiHaler) available for horses for the first time. The authorization of one established veterinary active ingredient was extended to an additional species: The anthelmintic fenbendazole (Gallifen) from the benzimidazole group is now also authorized for pheasants. Additionally, 3 veterinary drugs with a new combination of active ingredients (ketoprofen + tilmicosin, ketoprofen + tulathromycin, prednisolone + lidocaine), 3 agents in a novel pharmaceutical formulation (florfenicol, sodium hydrogen carbonate, prednisolone), one drug (fluralaner) in a new package size as well as a crystalloid balanced whole electrolyte solution with a potential base excess (BEpot) of 0 mmol/l were launched on the market for horses and food-producing animals.
2020年，一种用于马匹或食用动物的新型药物制剂在德国市场上市，使吸入性糖皮质激素环索奈德（Aservo EquiHaler）首次可供马匹使用。一种已获批准的兽用活性成分的适用范围扩大到了另一个物种：苯并咪唑类驱虫药芬苯达唑（Gallifen）现在也被批准用于雉鸡。此外，3种具有新活性成分组合的兽药（酮洛芬 + 替米考星、酮洛芬 + 泰拉霉素、泼尼松龙 + 利多卡因）、3种新型药物制剂（氟苯尼考、碳酸氢钠、泼尼松龙）、一种新包装规格的药物（氟拉纳）以及一种潜在碱剩余（BEpot）为0 mmol/L的晶体平衡全电解质溶液在马匹和食用动物市场上推出。
